Further evidence for a central antihypertensive effect of indorenate
Hong, E.; Rion, R.; Aceves, J.; Benitez-King, G.; Anton-Tay, F.
Proceedings of the Western Pharmacology Society 30: 1-3
1987
ISSN/ISBN: 0083-8969 PMID: 3476964 Document Number: 292070
Document emailed within 1 workday
Related Documents
Jacob, B.G.; Richter, W.O.; Schwandt, P. 1993: Effect of three antihypertensive drug groups on lipid metabolism. Effects of alpha receptor blockers, central sympatholytic drugs and vasodilators Fortschritte der Medizin 111(8): 126-129van Zwieten, P.A. 1973: The central action of antihypertensive drugs, mediated via central alpha-receptors Journal of Pharmacy and Pharmacology 25(2): 89-95
Rubenson, A. 1971: Analysis of the action of m-tyrosine on blood pressure in the conscious rat: evidence for a central hypotensive effect Journal of Pharmacy and Pharmacology 23(6): 412-419
Zawoiski, E.J. 1980: Central antihypertensive activity of propranolol Archives Internationales de Pharmacodynamie et de Therapie 243(1): 111-131
Mizuno, H.; Kimura, G. 2006: Evidence of antihypertensive therapy with diuretics Nihon Rinsho. Japanese Journal of Clinical Medicine 64(Suppl 6): 289-293
Wagstaff, A.; Moreno-Serra, R. 2009: Social health insurance and labor market outcomes: evidence from central and eastern Europe, and central Asia Advances in Health Economics and Health Services Research 21: 83-106
Karppanen, H. 1974: The central effective mechanism of antihypertensive agents Duodecim; Laaketieteellinen Aikakauskirja 90(13): 954-957
Lhoste, F.; Lagrue, G.; Nebout, T. 1982: Antihypertensive agents with central activity. Facts and perspectives La Revue du Praticien 32(41-42): 2695-2696 Passim
Pérez-Alvarez, V.; Bobadilla, R.A.; Hong, E. 1998: Direct effects of new indorenate analogs on blood pressure of pithed rats Proceedings of the Western Pharmacology Society 41: 95-97
Predel, G.; Hany, S.; Stimpel, M. 1986: Central nervous system side effects of antihypertensive drugs Schweizerische Rundschau für Medizin Praxis 75(24): 730-733
Béroniade, V. 1981: Antihypertensive drugs acting at the nervous system level. 2. Central action L'Union Medicale du Canada 110(12): 1034-1039
Campanacci, L.; Bellini, G.; Battilana, G.; Rigoni, A.; Cosenzi, A.; Carretta, R.; Puppis, E.; Pierini, B.; Faccini, L. 1984: Central alpha-adrenergic agonist antihypertensive drugs and renal failure La Clinica Terapeutica 109(4): 301-309
Kovács, T. 2014: The effect of angiotensin receptor blockers in cerebrovascular disorders and dementia: bonus in addition to the antihypertensive effect Ideggyogyaszati Szemle 67(5-6): 149-168
Hardin, J.M.; Andrejak, M.; Makdassi, R.; Gherbrand, J.D.; Fievet, P.; Schmit, J.L.; Roger, J.C.; Harichaux, P.; Kassouf, J.; Fournier, A. 1981: Control of hypertension and blood lactate during exercise. Comparison of central antihypertensive agents with the cardio-selective beta blockers metoprolol and atenolol Archives des Maladies du Coeur et des Vaisseaux 74(Special Issue): 117-124
Buccafusco, J.J.; Lapp, C.A.; Westbrooks, K.L.; Ernsberger, P. 1995: Role of medullary I1-imidazoline and alpha 2-adrenergic receptors in the antihypertensive responses evoked by central administration of clonidine analogs in conscious spontaneously hypertensive rats Journal of Pharmacology and Experimental Therapeutics 273(3): 1162-1171
Georgiev, V.P.; Petkova, B.P. 1975: Effect of p-chlorophenylalanine on the central nervous excitability threshold and on the activity of some central depressants Medical Biology 53(1): 47-50
Allen, J.H.; McKenney, J.M.; Stratton, M.A.; Link, K. 1982: Antihypertensive effect of hydrochlorothiazide administered once or twice daily Clinical Pharmacy 1(3): 239-243
Pathe, M.; Steimer, C.; Schwartz, J. 1982: Antihypertensive effect of betaxolol at increasing doses Therapie 37(1): 75-82
Viskoper, R.J.; Laszt, A.; Oren, S.; Hochberg, Y.; Villa, Y.; Drexler, I.; Bregman, L.; Mishal, J. 1989: The antihypertensive effect of atenolol and bopindolol in the elderly Netherlands Journal of Medicine 35(3-4): 185-191
Gomez, G. 1982: The effect of different antihypertensive therapies on plasma lipids Practitioner 226(1367): 985-991